Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States ...

Eisai and Biogen's Alzheimer's drug Leqembi continues to show promise in slowing disease progression, with no new safety issues observed over four years. The injectable form of Leqembi is under U.S.

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more ...

According to the latest study from BCC Research, the "Global Thyroid Gland Disorders: Diagnostics and Treatment Market" is ...

Sanofi's SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma <li /> Designation grante ...

Fueled by MAHA, state lawmakers are moving to remove dyes and other additives from food. A wide range of state laws could ...

Overview of Skeletal Dysplasia MarketThe Global Skeletal Dysplasia Market is valued at USD 3.42 Billion in 2024 and is ...

Media House leads cannabis SEO and dispensary marketing in 2025. Understand why it's the top-rated cannabis marketing agency driving revenue and compliance.

Can human beings cure all diseases in our lifetime? For centuries, humanity has strived to cure diseases. With the advent of Artificial ...

The “Make Health Tech Great Again" event is expected to provide more details on how the administration is advancing a “next-generation digital health ecosystem." ...